Cargando…

(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes

BACKGROUND: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, (44)Sc and (47)Sc, satisfies the desired physical aspects for PET imaging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domnanich, Katharina A., Müller, Cristina, Benešová, Martina, Dressler, Rugard, Haller, Stephanie, Köster, Ulli, Ponsard, Bernard, Schibli, Roger, Türler, Andreas, van der Meulen, Nicholas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824697/ https://www.ncbi.nlm.nih.gov/pubmed/29503846 http://dx.doi.org/10.1186/s41181-017-0024-x

Ejemplares similares

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
por: Müller, Cristina, et al.
Publicado: (2016)

Therapeutic Potential of (47)Sc in Comparison to (177)Lu and (90)Y: Preclinical Investigations
por: Siwowska, Klaudia, et al.
Publicado: (2019)

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017)

(44)Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
por: Domnanich, Katharina A., et al.
Publicado: (2016)

Production and separation of (43)Sc for radiopharmaceutical purposes
por: Domnanich, Katharina A., et al.
Publicado: (2017)

Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of  Differentiated Thyroid Cancer
por: Slonimsky, Einat, et al.
Publicado: (2020)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014)

Production, Collection, and Purification of (47)Ca for the Generation of (47)Sc through Isotope Harvesting at the National Superconducting Cyclotron Laboratory
por: Abel, E. Paige, et al.
Publicado: (2020)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021)

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with $^152$Tb-DOTATOC
por: Baum, Richard P, et al.
Publicado: (2017)

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate
por: Haller, Stephanie, et al.
Publicado: (2016)

High-resolution laser resonance ionization spectroscopy of [Formula: see text] Pm
por: Studer, Dominik, et al.
Publicado: (2020)

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Preclinical investigations and first-in-human application of $^{152}$Tb-PSMA-617 for PET/CT imaging of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Preclinical investigations and first-in-human application of (152)Tb-PSMA-617 for PET/CT imaging of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application
por: Ünak, Perihan, et al.
Publicado: (2023)

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Alpha-PET for Prostate Cancer: Preclinical investigation using (149)Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Production and characterization of (60)Fe standards for accelerator mass spectrometry
por: Schumann, Dorothea, et al.
Publicado: (2019)

Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy
por: Gracheva, Nadezda, et al.
Publicado: (2019)

Stability of (47)Sc-complexes with acyclic polyamino-polycarboxylate ligands
por: Połosak, Magdalena, et al.
Publicado: (2012)

(47)Sc production development by cyclotron irradiation of (48)Ca
por: Misiak, R., et al.
Publicado: (2017)

(161)Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of (161)Tb into the Clinic
por: Favaretto, Chiara, et al.
Publicado: (2023)

Cyclotron-based production of the theranostic radionuclides $^{67}$Cu and $^{47}$Sc
por: Pupillo, G, et al.
Publicado: (2019)

Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide (47)Sc
por: Loveless, C. Shaun, et al.
Publicado: (2019)

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
por: Müller, Cristina, et al.
Publicado: (2018)

Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
por: Borgna, Francesca, et al.
Publicado: (2021)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of (47)Sc as Example
por: Boschi, Alessandra, et al.
Publicado: (2019)

High precision half-life measurement of the extinct radio-lanthanide Dysprosium-154
por: Chiera, Nadine Mariel, et al.
Publicado: (2022)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Airaksinen, A, et al.
Publicado: (2016)

A Model for Radiolysis in a Flowing-Water Target during High-Intensity Proton Irradiation
por: Domnanich, Katharina A., et al.
Publicado: (2022)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Köster, Ulli
Publicado: (2017)

Radiochemical aspects of liquid mercury spallation targets
por: Neuhausen, Joerg, et al.
Publicado: (2012)

Clinical Translation and First In-Human Use of [(44)Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
por: Eppard, Elisabeth, et al.
Publicado: (2017)

Agenda for the 47th meeting of the PS and SC Committee to be held on Monday and Tuesday, 2-3 June, 1986
por: Fidecaro, M
Publicado: (1986)

Study of the $^{44}$Ti$(\alpha,p)^{47}$V47 reaction and implications for core collapse supernovae
por: Margerin, V, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rj1tnduvs9p9kmeq4odrm8jb97